Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Diseases
1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Diseases: 2018 VS 2024 VS 2034
1.2.2 Amoebic Dysentery
1.2.3 Antimalarial Drug
1.2.4 Leishmaniasis & Chagas Disease
1.3 Market by Application
1.3.1 Global Antiprotozoal Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiprotozoal Drugs Market Perspective (2018-2034)
2.2 Antiprotozoal Drugs Growth Trends by Region
2.2.1 Global Antiprotozoal Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2018-2023)
2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2024-2034)
2.3 Antiprotozoal Drugs Market Dynamics
2.3.1 Antiprotozoal Drugs Industry Trends
2.3.2 Antiprotozoal Drugs Market Drivers
2.3.3 Antiprotozoal Drugs Market Challenges
2.3.4 Antiprotozoal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiprotozoal Drugs Players by Revenue
3.1.1 Global Top Antiprotozoal Drugs Players by Revenue (2018-2023)
3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiprotozoal Drugs Revenue
3.4 Global Antiprotozoal Drugs Market Concentration Ratio
3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2024
3.5 Antiprotozoal Drugs Key Players Head office and Area Served
3.6 Key Players Antiprotozoal Drugs Product Solution and Service
3.7 Date of Enter into Antiprotozoal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiprotozoal Drugs Breakdown Data by Type
4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2018-2023)
4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2034)
5 Antiprotozoal Drugs Breakdown Data by Application
5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2018-2023)
5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antiprotozoal Drugs Market Size (2018-2034)
6.2 North America Antiprotozoal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Antiprotozoal Drugs Market Size by Country (2018-2023)
6.4 North America Antiprotozoal Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiprotozoal Drugs Market Size (2018-2034)
7.2 Europe Antiprotozoal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Antiprotozoal Drugs Market Size by Country (2018-2023)
7.4 Europe Antiprotozoal Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiprotozoal Drugs Market Size (2018-2034)
8.2 Asia-Pacific Antiprotozoal Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiprotozoal Drugs Market Size (2018-2034)
9.2 Latin America Antiprotozoal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Antiprotozoal Drugs Market Size by Country (2018-2023)
9.4 Latin America Antiprotozoal Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiprotozoal Drugs Market Size (2018-2034)
10.2 Middle East & Africa Antiprotozoal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Antiprotozoal Drugs Introduction
11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Akthelia Pharmaceuticals Ltd
11.2.1 Akthelia Pharmaceuticals Ltd Company Detail
11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.2.5 Akthelia Pharmaceuticals Ltd Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Detail
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Immuron Ltd
11.4.1 Immuron Ltd Company Detail
11.4.2 Immuron Ltd Business Overview
11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.4.5 Immuron Ltd Recent Development
11.5 Microbiotix Inc
11.5.1 Microbiotix Inc Company Detail
11.5.2 Microbiotix Inc Business Overview
11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.5.5 Microbiotix Inc Recent Development
11.6 Protein Potential LLC
11.6.1 Protein Potential LLC Company Detail
11.6.2 Protein Potential LLC Business Overview
11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023)
11.6.5 Protein Potential LLC Recent Development
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Company Detail
11.7.2 Dr. Reddy’s Laboratories Business Overview
11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction
11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.7.5 Dr. Reddy’s Laboratories Recent Development
11.8 Mission Pharmacal
11.8.1 Mission Pharmacal Company Detail
11.8.2 Mission Pharmacal Business Overview
11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023)
11.8.5 Mission Pharmacal Recent Development
11.9 Aceto Corp.
11.9.1 Aceto Corp. Company Detail
11.9.2 Aceto Corp. Business Overview
11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023)
11.9.5 Aceto Corp. Recent Development
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Detail
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.10.5 Mylan Pharmaceuticals Recent Development
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Detail
11.11.2 Impax Laboratories Business Overview
11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.11.5 Impax Laboratories Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Antiprotozoal Drugs Introduction
11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Detail
11.13.2 Lupin Pharmaceuticals Business Overview
11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.13.5 Lupin Pharmaceuticals Recent Development
11.14 Glenmark Pharmaceuticals
11.14.1 Glenmark Pharmaceuticals Company Detail
11.14.2 Glenmark Pharmaceuticals Business Overview
11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.14.5 Glenmark Pharmaceuticals Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Detail
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023)
11.15.5 Sun Pharmaceutical Recent Development
11.16 Heritage Pharmaceuticals
11.16.1 Heritage Pharmaceuticals Company Detail
11.16.2 Heritage Pharmaceuticals Business Overview
11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.16.5 Heritage Pharmaceuticals Recent Development
11.17 Gilead Sciences
11.17.1 Gilead Sciences Company Detail
11.17.2 Gilead Sciences Business Overview
11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023)
11.17.5 Gilead Sciences Recent Development
11.18 Johnson & Johnson
11.18.1 Johnson & Johnson Company Detail
11.18.2 Johnson & Johnson Business Overview
11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023)
11.18.5 Johnson & Johnson Recent Development
11.19 Bristol-Myers Squibb
11.19.1 Bristol-Myers Squibb Company Detail
11.19.2 Bristol-Myers Squibb Business Overview
11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023)
11.19.5 Bristol-Myers Squibb Recent Development
11.20 Profounda
11.20.1 Profounda Company Detail
11.20.2 Profounda Business Overview
11.20.3 Profounda Antiprotozoal Drugs Introduction
11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2018-2023)
11.20.5 Profounda Recent Development
11.21 Knight Therapeutics
11.21.1 Knight Therapeutics Company Detail
11.21.2 Knight Therapeutics Business Overview
11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023)
11.21.5 Knight Therapeutics Recent Development
11.22 Albert David
11.22.1 Albert David Company Detail
11.22.2 Albert David Business Overview
11.22.3 Albert David Antiprotozoal Drugs Introduction
11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2018-2023)
11.22.5 Albert David Recent Development
11.23 Wanlong
11.23.1 Wanlong Company Detail
11.23.2 Wanlong Business Overview
11.23.3 Wanlong Antiprotozoal Drugs Introduction
11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023)
11.23.5 Wanlong Recent Development
11.24 Fangsheng
11.24.1 Fangsheng Company Detail
11.24.2 Fangsheng Business Overview
11.24.3 Fangsheng Antiprotozoal Drugs Introduction
11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023)
11.24.5 Fangsheng Recent Development
11.25 KPC Pharmaceuticals
11.25.1 KPC Pharmaceuticals Company Detail
11.25.2 KPC Pharmaceuticals Business Overview
11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.25.5 KPC Pharmaceuticals Recent Development
11.26 Guilin Pharmaceuticals
11.26.1 Guilin Pharmaceuticals Company Detail
11.26.2 Guilin Pharmaceuticals Business Overview
11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.26.5 Guilin Pharmaceuticals Recent Development
11.27 Pude Pharmaceutica
11.27.1 Pude Pharmaceutica Company Detail
11.27.2 Pude Pharmaceutica Business Overview
11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023)
11.27.5 Pude Pharmaceutica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Amoebic Dysentery
Table 3. Key Players of Antimalarial Drug
Table 4. Key Players of Leishmaniasis & Chagas Disease
Table 5. Global Antiprotozoal Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Antiprotozoal Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Antiprotozoal Drugs Market Share by Region (2018-2023)
Table 9. Global Antiprotozoal Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Antiprotozoal Drugs Market Share by Region (2024-2034)
Table 11. Antiprotozoal Drugs Market Trends
Table 12. Antiprotozoal Drugs Market Drivers
Table 13. Antiprotozoal Drugs Market Challenges
Table 14. Antiprotozoal Drugs Market Restraints
Table 15. Global Antiprotozoal Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Antiprotozoal Drugs Market Share by Players (2018-2023)
Table 17. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2024)
Table 18. Ranking of Global Top Antiprotozoal Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiprotozoal Drugs Product Solution and Service
Table 22. Date of Enter into Antiprotozoal Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Antiprotozoal Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Antiprotozoal Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Antiprotozoal Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Antiprotozoal Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Antiprotozoal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Antiprotozoal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Antiprotozoal Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Antiprotozoal Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Antiprotozoal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Antiprotozoal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Antiprotozoal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Antiprotozoal Drugs Product
Table 50. Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Akthelia Pharmaceuticals Ltd Company Detail
Table 53. Akthelia Pharmaceuticals Ltd Business Overview
Table 54. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product
Table 55. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 56. Akthelia Pharmaceuticals Ltd Recent Development
Table 57. GlaxoSmithKline Plc Company Detail
Table 58. GlaxoSmithKline Plc Business Overview
Table 59. GlaxoSmithKline Plc Antiprotozoal Drugs Product
Table 60. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Plc Recent Development
Table 62. Immuron Ltd Company Detail
Table 63. Immuron Ltd Business Overview
Table 64. Immuron Ltd Antiprotozoal Drugs Product
Table 65. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 66. Immuron Ltd Recent Development
Table 67. Microbiotix Inc Company Detail
Table 68. Microbiotix Inc Business Overview
Table 69. Microbiotix Inc Antiprotozoal Drugs Product
Table 70. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 71. Microbiotix Inc Recent Development
Table 72. Protein Potential LLC Company Detail
Table 73. Protein Potential LLC Business Overview
Table 74. Protein Potential LLC Antiprotozoal Drugs Product
Table 75. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 76. Protein Potential LLC Recent Development
Table 77. Dr. Reddy’s Laboratories Company Detail
Table 78. Dr. Reddy’s Laboratories Business Overview
Table 79. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product
Table 80. Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 81. Dr. Reddy’s Laboratories Recent Development
Table 82. Mission Pharmacal Company Detail
Table 83. Mission Pharmacal Business Overview
Table 84. Mission Pharmacal Antiprotozoal Drugs Product
Table 85. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 86. Mission Pharmacal Recent Development
Table 87. Aceto Corp. Company Detail
Table 88. Aceto Corp. Business Overview
Table 89. Aceto Corp. Antiprotozoal Drugs Product
Table 90. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 91. Aceto Corp. Recent Development
Table 92. Mylan Pharmaceuticals Company Detail
Table 93. Mylan Pharmaceuticals Business Overview
Table 94. Mylan Pharmaceuticals Antiprotozoal Drugs Product
Table 95. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 96. Mylan Pharmaceuticals Recent Development
Table 97. Impax Laboratories Company Detail
Table 98. Impax Laboratories Business Overview
Table 99. Impax Laboratories Antiprotozoal Drugs Product
Table 100. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 101. Impax Laboratories Recent Development
Table 102. Pfizer Company Detail
Table 103. Pfizer Business Overview
Table 104. Pfizer Antiprotozoal Drugs Product
Table 105. Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Lupin Pharmaceuticals Company Detail
Table 108. Lupin Pharmaceuticals Business Overview
Table 109. Lupin Pharmaceuticals Antiprotozoal Drugs Product
Table 110. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 111. Lupin Pharmaceuticals Recent Development
Table 112. Glenmark Pharmaceuticals Company Detail
Table 113. Glenmark Pharmaceuticals Business Overview
Table 114. Glenmark Pharmaceuticals Antiprotozoal Drugs Product
Table 115. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 116. Glenmark Pharmaceuticals Recent Development
Table 117. Sun Pharmaceutical Company Detail
Table 118. Sun Pharmaceutical Business Overview
Table 119. Sun Pharmaceutical Antiprotozoal Drugs Product
Table 120. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 121. Sun Pharmaceutical Recent Development
Table 122. Heritage Pharmaceuticals Company Detail
Table 123. Heritage Pharmaceuticals Business Overview
Table 124. Heritage Pharmaceuticals Antiprotozoal Drugs Product
Table 125. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 126. Heritage Pharmaceuticals Recent Development
Table 127. Gilead Sciences Company Detail
Table 128. Gilead Sciences Business Overview
Table 129. Gilead Sciences Antiprotozoal Drugs Product
Table 130. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 131. Gilead Sciences Recent Development
Table 132. Johnson & Johnson Company Detail
Table 133. Johnson & Johnson Business Overview
Table 134. Johnson & Johnson Antiprotozoal Drugs Product
Table 135. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 136. Johnson & Johnson Recent Development
Table 137. Bristol-Myers Squibb Company Detail
Table 138. Bristol-Myers Squibb Business Overview
Table 139. Bristol-Myers Squibb Antiprotozoal Drugs Product
Table 140. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 141. Bristol-Myers Squibb Recent Development
Table 142. Profounda Company Detail
Table 143. Profounda Business Overview
Table 144. Profounda Antiprotozoal Drugs Product
Table 145. Profounda Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 146. Profounda Recent Development
Table 147. Knight Therapeutics Company Detail
Table 148. Knight Therapeutics Business Overview
Table 149. Knight Therapeutics Antiprotozoal Drugs Product
Table 150. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 151. Knight Therapeutics Recent Development
Table 152. Albert David Company Detail
Table 153. Albert David Business Overview
Table 154. Albert David Antiprotozoal Drugs Product
Table 155. Albert David Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 156. Albert David Recent Development
Table 157. Wanlong Company Detail
Table 158. Wanlong Business Overview
Table 159. Wanlong Antiprotozoal Drugs Product
Table 160. Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 161. Wanlong Recent Development
Table 162. Fangsheng Company Detail
Table 163. Fangsheng Business Overview
Table 164. Fangsheng Antiprotozoal Drugs Product
Table 165. Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 166. Fangsheng Recent Development
Table 167. KPC Pharmaceuticals Company Detail
Table 168. KPC Pharmaceuticals Business Overview
Table 169. KPC Pharmaceuticals Antiprotozoal Drugs Product
Table 170. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 171. KPC Pharmaceuticals Recent Development
Table 172. Guilin Pharmaceuticals Company Detail
Table 173. Guilin Pharmaceuticals Business Overview
Table 174. Guilin Pharmaceuticals Antiprotozoal Drugs Product
Table 175. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 176. Guilin Pharmaceuticals Recent Development
Table 177. Pude Pharmaceutica Company Detail
Table 178. Pude Pharmaceutica Business Overview
Table 179. Pude Pharmaceutica Antiprotozoal Drugs Product
Table 180. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 181. Pude Pharmaceutica Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiprotozoal Drugs Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Antiprotozoal Drugs Market Share by Type: 2024 VS 2034
Figure 3. Amoebic Dysentery Features
Figure 4. Antimalarial Drug Features
Figure 5. Leishmaniasis & Chagas Disease Features
Figure 6. Global Antiprotozoal Drugs Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Antiprotozoal Drugs Market Share by Application: 2024 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Antiprotozoal Drugs Report Years Considered
Figure 11. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Antiprotozoal Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Antiprotozoal Drugs Market Share by Region: 2024 VS 2034
Figure 14. Global Antiprotozoal Drugs Market Share by Players in 2024
Figure 15. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2024
Figure 17. North America Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Antiprotozoal Drugs Market Share by Country (2018-2034)
Figure 19. United States Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Antiprotozoal Drugs Market Share by Country (2018-2034)
Figure 23. Germany Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Antiprotozoal Drugs Market Share by Region (2018-2034)
Figure 31. China Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Antiprotozoal Drugs Market Share by Country (2018-2034)
Figure 39. Mexico Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Antiprotozoal Drugs Market Share by Country (2018-2034)
Figure 43. Turkey Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 46. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 47. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 48. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 49. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 50. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 51. Dr. Reddy’s Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 52. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 53. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 54. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 55. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 58. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 59. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 60. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 61. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 62. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 64. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 65. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 66. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 67. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 68. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 69. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 70. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 71. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed